Fluanisone
Clinical data
ATC code
Identifiers
  • 1-(4-Fluorophenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]butan-1-one
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.014.581
Chemical and physical data
FormulaC21H25FN2O2
Molar mass356.441 g·mol−1
3D model (JSmol)
  • Fc1ccc(cc1)C(=O)CCCN3CCN(c2ccccc2OC)CC3
  • InChI=1S/C21H25FN2O2/c1-26-21-7-3-2-5-19(21)24-15-13-23(14-16-24)12-4-6-20(25)17-8-10-18(22)11-9-17/h2-3,5,7-11H,4,6,12-16H2,1H3 checkY
  • Key:IRYFCWPNDIUQOW-UHFFFAOYSA-N checkY
  (verify)

Fluanisone is a typical antipsychotic and sedative of the butyrophenone chemical class.[1] It is used in the treatment of schizophrenia and mania. It is also a component (along with fentanyl) of the injectable veterinary formulation fentanyl/fluanisone (Hypnorm)[2] where it is used for rodent analgesia during short surgical procedures.

See also

References

  1. ↑ Janssen PA (1967). "Haloperidol and related butyrophenones". In Gordon M (ed.). Psychopharmacological agents. Medicinal Chemistry. Vol. 2. New York: Academic Press. pp. 199–248 (227). ISBN 978-1-4832-7446-1.
  2. ↑ "Fluanisone". drugs.com.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.